|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.4 USD | +1.36% |
|
+3.24% | +3.45% |
| Apr. 30 | Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology | CI |
| Apr. 26 | Wall Street: the worst week of 2024 is followed by the best | CF |
DexCom, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 921 million compared to USD 741.5 million a year ago. Net income was USD 146.4 million compared to USD 48.6 million a year ago.
Basic earnings per share from continuing operations was USD 0.38 compared to USD 0.13 a year ago. Diluted earnings per share from continuing operations was USD 0.36 compared to USD 0.12 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.45% | 51.05B | |
| -3.79% | 184B | |
| -0.84% | 108B | |
| -3.75% | 67.82B | |
| +9.04% | 44.67B | |
| +3.40% | 41.78B | |
| +3.21% | 26.78B | |
| +3.66% | 26.59B | |
| +15.23% | 25.86B | |
| -0.03% | 25.03B |
DEXCOM, INC. 
